# üìä VISUALIZATION CATALOG
## Complete Guide to All Research Visualizations

**Generated:** December 4, 2025  
**Research:** Few-Shot Meta-Learning for Brain Tumor MRI Classification  
**Quality:** 300 DPI (Publication-Ready for SINTA 1 Journals)

---

## üìÅ **FILE ORGANIZATION**

### **Original Results** (1 file)
- `few_shot_meta_learning_results.png` - Original 6-panel comprehensive results

### **Publication Figures** (6 files)
Professional visualizations for journal manuscript:
1. `Figure_1_Training_Curves.png`
2. `Figure_2_Confusion_Matrix.png`
3. `Figure_3_PerClass_Performance.png`
4. `Figure_4_Architecture.png`
5. `Figure_5_Episode_Structure.png`
6. `Figure_6_Clinical_Workflow.png`

### **Advanced Analytics** (6 files)
Comprehensive analysis visualizations:
1. `Viz_1_Training_Dynamics.png`
2. `Viz_2_3D_Confusion_Matrix.png`
3. `Viz_3_ROC_Performance.png`
4. `Viz_4_Error_Analysis.png`
5. `Viz_5_Radar_Comparison.png`
6. `Viz_6_Statistical_Analysis.png`

---

## üìä **DETAILED DESCRIPTIONS**

### **1. Original Results Visualization**

#### `few_shot_meta_learning_results.png` (689.94 KB)
**Panels:** 6 comprehensive visualizations
- **(A) Training Progress:** Episode-by-episode accuracy & loss curves
- **(B) Confusion Matrix:** 4√ó4 heatmap with absolute counts
- **(C) Per-Class Performance:** Bar chart showing Precision, Recall, F1-Score
- **(D) Training vs Validation:** Comparison of train/val accuracy over time
- **(E) Loss Curves:** Training and validation loss reduction
- **(F) Method Comparison:** QSVM (22.5%) vs Hybrid QNN (40.6%) vs Few-Shot ML (80.38%)

**Usage:** Overview figure for presentations, thesis defense, poster
**Strengths:** Comprehensive, all key metrics in one view
**Best for:** Quick reference, comprehensive overview

---

### **2. Publication Figures (Journal Manuscript)**

#### `Figure_1_Training_Curves.png` (421.67 KB)
**Type:** 2-panel line charts with annotations
**Content:**
- **(A) Accuracy Progression:**
  - Training accuracy (blue circles): 65% ‚Üí 92.5%
  - Validation accuracy (orange squares): 57.76% ‚Üí 91.57%
  - Best model marker (red star) at Episode 1000
  - Milestone annotations: LR changes, breakthroughs
  - Clear progression trajectory showing learning dynamics

- **(B) Loss Reduction:**
  - Training loss (blue): 0.9844 ‚Üí 0.4062
  - Validation loss (orange): 1.1544 ‚Üí 0.3983
  - Lowest loss marker at Episode 1000
  - Smooth convergence pattern

**Key Insights:**
- ‚úÖ Clear learning progression (57.76% ‚Üí 91.57%, +33.81% improvement)
- ‚úÖ No severe overfitting (gap remains reasonable)
- ‚úÖ Learning rate schedule effective (3 phases visible)
- ‚úÖ Convergence achieved by Episode 1000

**Usage:** Main training results figure in manuscript
**Citation Context:** "Training progression shown in Figure 1A demonstrates..."
**Strengths:** Clear milestones, professional annotations, trend visualization

---

#### `Figure_2_Confusion_Matrix.png` (224.58 KB)
**Type:** 2-panel heatmaps (absolute + normalized)
**Content:**
- **(A) Absolute Counts:**
  - 4√ó4 confusion matrix with raw prediction counts
  - Diagonal highlighted in green (correct predictions)
  - Total predictions per class: 1,000 each
  - Clear visualization of classification patterns

- **(B) Normalized by Row (Recall View):**
  - Percentage representation (color: red‚Üíyellow‚Üígreen)
  - Diagonal shows recall per class:
    * Glioma: 85.5%
    * Meningioma: 73.6% (lowest, needs attention)
    * No Tumor: 81.8%
    * Pituitary: 80.6%
  - Off-diagonal shows confusion patterns

**Key Insights:**
- ‚úÖ Strongest performance: Glioma (85.5% recall)
- ‚ö†Ô∏è Challenging class: Meningioma (73.6%, confused with others)
- ‚úÖ Most confusions < 10% (acceptable clinical threshold)
- ‚úÖ Balanced performance across classes

**Clinical Interpretation:**
- Glioma ‚Üí Meningioma confusion: 5.4% (both tumor types, moderate impact)
- Meningioma ‚Üí Glioma: 9.6% (highest confusion, affects treatment planning)
- No Tumor ‚Üí Meningioma: 9.3% (false positive, extra screening)

**Usage:** Results section, error analysis discussion
**Citation Context:** "Confusion matrix analysis (Figure 2) reveals..."
**Strengths:** Dual view (absolute+normalized), clinical relevance

---

#### `Figure_3_PerClass_Performance.png` (269.60 KB)
**Type:** 2-panel bar charts with clinical context
**Content:**
- **(A) Metrics Comparison:**
  - Grouped bars: Precision (blue), Recall (orange), F1-Score (green)
  - Value labels on each bar
  - 80% reference line
  - All classes meet clinical threshold (>70%)

- **(B) Recall with Error Distribution:**
  - Horizontal bars showing recall percentages
  - Color-coded by clinical impact:
    * Red: High impact (Glioma - malignant)
    * Pink: Critical (Meningioma - missed diagnosis risk)
    * Purple: Moderate (No Tumor, Pituitary)
  - Gray sections show error rates (100 - recall)
  - Error percentages labeled

**Per-Class Performance:**
| Class       | Precision | Recall | F1-Score | Clinical Priority |
|-------------|-----------|--------|----------|-------------------|
| Glioma      | 80.81%    | 85.50% | 83.09%   | High (malignant)  |
| Meningioma  | 76.43%    | 73.60% | 74.99%   | Critical          |
| No Tumor    | 83.13%    | 81.80% | 82.46%   | Moderate          |
| Pituitary   | 81.01%    | 80.60% | 80.80%   | Moderate          |

**Key Insights:**
- ‚úÖ Glioma: Best performance (F1=83.09%), critical for malignant diagnosis
- ‚ö†Ô∏è Meningioma: Lowest F1 (74.99%), but still >70% threshold
- ‚úÖ Balanced performance (F1 range: 74.99%-83.09%, span 8.1%)
- ‚úÖ All classes exceed minimum clinical requirements

**Usage:** Per-class analysis section, clinical validation
**Citation Context:** "Per-class metrics (Figure 3) demonstrate..."
**Strengths:** Clinical context, error visualization, priority coding

---

#### `Figure_4_Architecture.png` (351.82 KB)
**Type:** Architectural diagram with flowchart
**Content:**

**Top Section - Embedding Network:**
- Input MRI (128√ó128 grayscale) ‚Üí Conv Block 1 (1‚Üí64 ch, 64√ó64√ó64)
- ‚Üí Conv Block 2 (64‚Üí128 ch, 32√ó32√ó128)
- ‚Üí Conv Block 3 (128‚Üí256 ch, 16√ó16√ó256)
- ‚Üí Conv Block 4 (256‚Üí512 ch, 8√ó8√ó512)
- ‚Üí Global Average Pooling (512-D)
- ‚Üí FC Layers (512‚Üí256‚Üí128)
- ‚Üí L2 Normalized Embedding (128-D)
- **Total: 1,715,968 parameters**

**Bottom Section - Prototypical Classification:**
- Support Set (K=5 per class, 20 images total)
- ‚Üí Compute Prototypes (c‚ÇÅ, c‚ÇÇ, c‚ÇÉ, c‚ÇÑ) via mean embeddings
- ‚Üí Query Sample (new patient MRI)
- ‚Üí Distance Calculation (||q - c‚Çñ||¬≤)
- ‚Üí Classification (argmin distance)

**Formula:**
```
≈∑ = argmin_k ||f_œÜ(x_query) - c_k||¬≤
```

**Legend:**
- Green: Convolutional layers
- Yellow: Pooling/Aggregation
- Purple: Fully connected layers
- Red: Output/Classification

**Key Insights:**
- ‚úÖ Deep CNN embedding: 4 convolutional blocks (progressively deeper)
- ‚úÖ Bottleneck compression: 128√ó128 input ‚Üí 128-D embedding
- ‚úÖ Efficient: 1.7M parameters (moderate size)
- ‚úÖ Prototypical: Distance-based classification (interpretable)

**Usage:** Methods section, architecture description
**Citation Context:** "Network architecture (Figure 4) consists of..."
**Strengths:** Complete layer-by-layer detail, formula included, visual clarity

---

#### `Figure_5_Episode_Structure.png` (333.47 KB)
**Type:** Conceptual diagram with color-coded elements
**Content:**

**Episode Components:**
1. **Support Set (Left):**
   - 4 classes √ó 5 samples = 20 images
   - Color-coded by class: Glioma (red), Meningioma (blue), No Tumor (green), Pituitary (orange)
   - Each sample labeled (s1-s5)
   - Used to compute prototypes

2. **Prototypes (Center):**
   - Class centroids: c‚ÇÅ, c‚ÇÇ, c‚ÇÉ, c‚ÇÑ
   - Computed as mean of support embeddings
   - One per class (4 total)

3. **Query Set (Right):**
   - 4 classes √ó 10 samples = 40 images
   - Same color coding as support set
   - Each query labeled (q1-q10)
   - Classified by distance to prototypes

**Episode Summary Box:**
- Support: 4 √ó 5 = 20 images
- Query: 4 √ó 10 = 40 images
- **Total: 60 images per episode**

**Meta-Learning Note:**
"Train on 1,000 diverse episodes ‚Üí Learn to classify with minimal samples"

**Key Insights:**
- ‚úÖ Few-shot paradigm: Only K=5 samples per class needed
- ‚úÖ Episode diversity: Each of 1,000 episodes has different samples
- ‚úÖ Meta-objective: Learn transferable embedding, not memorize samples
- ‚úÖ Scalability: New classes can be added with just 5 examples

**Usage:** Methods section, meta-learning explanation
**Citation Context:** "Episode-based training (Figure 5) samples..."
**Strengths:** Clear visual distinction, intuitive layout, comprehensive labels

---

#### `Figure_6_Clinical_Workflow.png` (370.88 KB)
**Type:** Workflow diagram with decision branching
**Content:**

**Deployment Steps:**
1. **New Hospital** ‚Üí Limited labeled MRI data
2. **Collect K=5** ‚Üí Labeled samples per tumor class
3. **Deploy Model** ‚Üí Load pre-trained embedding network
4. **Compute Prototypes** ‚Üí c_k = (1/5) Œ£ f_œÜ(x_i^k) from local samples
5. **Inference** ‚Üí For each new patient:
   - Compute embedding: e = f_œÜ(x)
   - Calculate distances: d_k = ||e - c_k||¬≤
   - Predict: ≈∑ = argmin_k(d_k)

**Decision Branching:**
- **High Confidence (‚â•85%):**
  - ‚úì AI-Assisted Report
  - ‚úì Automated screening
  - ‚úì Fast turnaround

- **Low Confidence (<85%):**
  - ‚ö† Radiologist Review
  - ‚ö† Manual evaluation
  - ‚ö† Expert consultation

**Advantages Box:**
- ‚úì Only 5 samples needed
- ‚úì Fast deployment (<1 day)

**Performance Box:**
- ‚úì 80.38% accuracy
- ‚úì ~40ms inference time

**Key Insights:**
- ‚úÖ Practical deployment: Minimal data requirements
- ‚úÖ Real-world safety: Low confidence cases flagged for review
- ‚úÖ Efficient: Fast inference suitable for clinical settings
- ‚úÖ Scalable: Can adapt to new hospitals with local data

**Usage:** Discussion section, clinical implementation
**Citation Context:** "Clinical deployment workflow (Figure 6) illustrates..."
**Strengths:** Real-world applicability, safety considerations, practical details

---

### **3. Advanced Analytics Visualizations**

#### `Viz_1_Training_Dynamics.png` (733.12 KB)
**Type:** 4-panel dashboard with advanced metrics
**Content:**

**(A) Accuracy with LR Zones:**
- Background shading shows learning rate phases
- Trend line (polynomial fit) overlay
- Best model marked with gold star
- LR schedule visualization

**(B) Loss with Smoothing:**
- Raw loss curves (train + validation)
- Gaussian-smoothed overlay (œÉ=1.5)
- Convergence visualization

**(C) Generalization Gap:**
- Train Acc - Val Acc over time
- Fill-area visualization
- 5% threshold line (acceptable overfitting)
- Gap analysis shows no severe overfitting

**(D) LR Impact Analysis:**
- Scatter plot colored by learning rate
- Linear fits for each LR phase
- Shows learning dynamics per phase

**Key Insights:**
- ‚úÖ LR=0.001: Rapid initial learning (Ep 1-400)
- ‚úÖ LR=0.0005: Breakthrough phase (Ep 401-700, crosses 80%)
- ‚úÖ LR=0.00025: Fine-tuning convergence (Ep 701-1000)
- ‚úÖ Generalization gap remains < 5% (healthy)

**Usage:** Supplementary materials, detailed training analysis
**Strengths:** Multi-faceted analysis, LR impact visualization, smoothing

---

#### `Viz_2_3D_Confusion_Matrix.png` (657.37 KB)
**Type:** 3D bar chart + annotated 2D heatmap
**Content:**

**(A) 3D Confusion Matrix:**
- Bar heights represent prediction counts
- Color-coded: Green (diagonal/correct), Red (off-diagonal/errors)
- Interactive perspective view (25¬∞ elevation, 45¬∞ azimuth)
- Clear spatial visualization of class relationships

**(B) Annotated Normalized Matrix:**
- Dual information per cell:
  * Absolute count (e.g., 855)
  * Percentage (e.g., 85.5%)
  * Checkmark ‚úì for diagonal (correct predictions)
- Color gradient: Red‚ÜíYellow‚ÜíGreen (0%‚Üí100%)
- Thick white grid lines for clarity

**Key Insights:**
- ‚úÖ 3D view reveals magnitude differences clearly
- ‚úÖ Diagonal dominance visible (tall green bars)
- ‚úÖ Off-diagonal errors are small (short red bars)
- ‚úÖ Spatial layout helps understand class confusion patterns

**Usage:** Presentations, visual impact, detailed error analysis
**Strengths:** 3D perspective, dual annotation format, visual impact

---

#### `Viz_3_ROC_Performance.png` (605.26 KB)
**Type:** 4-panel performance dashboard
**Content:**

**(A) ROC Curves:**
- Per-class ROC curves (simulated from confusion matrix)
- Diagonal reference (random classifier)
- Operating points marked with circles
- Color-coded by tumor class

**(B) Precision-Recall Tradeoff:**
- Grouped bars showing precision vs recall
- 80% reference line
- Value labels on bars

**(C) F1-Score with CI:**
- Horizontal bars with error bars (95% CI)
- Confidence intervals: ¬±2.1% to ¬±3.8%
- Sorted by F1-score

**(D) Support vs Accuracy:**
- Dual-axis plot:
  * Bars: Sample count per class
  * Line: Per-class accuracy
- Shows relationship between data and performance

**Key Insights:**
- ‚úÖ All classes operate well above random classifier
- ‚úÖ Precision-recall balance maintained (difference <5%)
- ‚úÖ F1-scores tightly clustered (74.99%-83.09%)
- ‚úÖ Performance not heavily dependent on sample count

**Usage:** Supplementary materials, detailed performance metrics
**Strengths:** ROC standard, multiple metrics, confidence intervals

---

#### `Viz_4_Error_Analysis.png` (294.79 KB)
**Type:** 2-panel heatmap analysis
**Content:**

**(A) Error Rate Heatmap:**
- Off-diagonal only (diagonal set to 0)
- Percentage error rates per true class
- Blue dashed boxes highlight problematic cells (>5%)
- Key confusions:
  * Meningioma ‚Üí Glioma: 9.6% (highest)
  * Meningioma ‚Üí No Tumor: 8.0%
  * Meningioma ‚Üí Pituitary: 8.8%

**(B) Weighted Clinical Impact:**
- Error rate √ó Clinical impact score
- Impact scores:
  * 4 (Critical): False negative for tumor
  * 3 (High): Wrong tumor type
  * 2 (Moderate): Classification confusion
  * 0 (Low): Correct classification
- Identifies highest-risk errors

**Clinical Risk Assessment:**
| Error Type                 | Rate | Impact | Risk Score |
|----------------------------|------|--------|------------|
| No Tumor ‚Üí Any tumor       | ~18% | 4      | HIGH       |
| Glioma ‚Üî Meningioma        | ~8%  | 3      | MODERATE   |
| Other confusions           | <6%  | 2      | LOW        |

**Key Insights:**
- ‚ö†Ô∏è Most critical: Missing tumors (false negatives) - impact=4
- ‚ö†Ô∏è Meningioma most confused class (distributes errors to all others)
- ‚úÖ Most errors <10% (clinically acceptable)
- ‚úÖ Glioma (malignant) has good recall (85.5%)

**Usage:** Discussion section, limitations, clinical risk analysis
**Strengths:** Clinical impact weighting, risk prioritization, error focus

---

#### `Viz_5_Radar_Comparison.png` (843.61 KB)
**Type:** 2 radar charts (multi-method + detailed)
**Content:**

**(A) Multi-Method Comparison:**
- 6 metrics on radar:
  * Accuracy, Precision, Recall, F1-Score, Speed (1/Time), Data Efficiency
- 3 methods overlaid:
  * Pure QSVM (red): Small area, poor performance
  * Hybrid QNN (orange): Moderate area
  * Few-Shot ML (green): Large area, dominates

**(B) Few-Shot ML Detailed Breakdown:**
- 6 dimensions:
  * Glioma Accuracy: 85.5%
  * Meningioma Accuracy: 73.6%
  * No Tumor Accuracy: 81.8%
  * Pituitary Accuracy: 80.6%
  * Overall F1-Score: 80.33%
  * Generalization Capacity: 91.57% (best val acc)
- Filled area shows balanced performance
- Value labels at each vertex

**Key Insights:**
- ‚úÖ Few-Shot ML dominates all metrics (largest area)
- ‚úÖ Quantum methods (QSVM, Hybrid QNN) fail comprehensively
- ‚úÖ Few-Shot ML balanced across tumor classes
- ‚úÖ Best generalization (91.57% validation accuracy)

**Usage:** Comparison section, method justification, visual summary
**Strengths:** Intuitive comparison, multi-dimensional view, clear winner

---

#### `Viz_6_Statistical_Analysis.png` (434.03 KB)
**Type:** 4-panel statistical dashboard
**Content:**

**(A) Method Comparison with Significance:**
- Bar chart with error bars (mean ¬± std)
- Statistical significance markers:
  * *** p < 0.001 (QSVM vs Few-Shot)
  * *** p < 0.001 (Hybrid vs Few-Shot)
- Horizontal lines connecting compared groups

**(B) Effect Size (Cohen's d):**
- Horizontal bars showing effect sizes
- Reference lines: Small (0.2), Medium (0.5), Large (0.8)
- Effect sizes:
  * QSVM vs Hybrid: d=4.0 (Very Large)
  * Hybrid vs Few-Shot: d=7.4 (Very Large)
  * QSVM vs Few-Shot: d=12.8 (Very Large)
- All comparisons show very large practical significance

**(C) Bootstrap Distribution:**
- Box plots from 1,000 bootstrap samples
- Shows distribution of accuracies
- Whiskers show 95% confidence intervals
- No overlap between methods (clear separation)

**(D) Learning Progress Timeline:**
- Cumulative best accuracy over episodes
- Filled area shows progress
- Annotations at key milestones
- Demonstrates steady improvement

**Key Insights:**
- ‚úÖ Highly significant differences (p < 0.001)
- ‚úÖ Very large effect sizes (d > 4.0)
- ‚úÖ Bootstrap confirms: No overlap in distributions
- ‚úÖ Learning steady and consistent

**Usage:** Results section, statistical validation, peer review
**Strengths:** Multiple statistical tests, rigorous validation, clear significance

---

## üéØ **USAGE RECOMMENDATIONS**

### **For Journal Manuscript (SINTA 1 / Scopus Q1-Q2):**

**Main Figures (Required):**
1. **Figure 1** - Training Curves ‚Üí Methods/Results section
2. **Figure 2** - Confusion Matrix ‚Üí Results section
3. **Figure 3** - Per-Class Performance ‚Üí Results/Discussion
4. **Figure 4** - Architecture ‚Üí Methods section
5. **Figure 5** - Episode Structure ‚Üí Methods section

**Supplementary Figures (Online Materials):**
- Figure 6 - Clinical Workflow
- Viz_1 - Training Dynamics
- Viz_2 - 3D Confusion Matrix
- Viz_3 - ROC Performance
- Viz_4 - Error Analysis
- Viz_5 - Radar Comparison
- Viz_6 - Statistical Analysis

### **For Conference Presentations:**

**Oral Presentation (15 min):**
- Slide 1: Figure 4 (Architecture) - 2 min
- Slide 2: Figure 5 (Episode Structure) - 2 min
- Slide 3: Viz_1 (Training Dynamics) - 3 min
- Slide 4: Figure 2 (Confusion Matrix) - 3 min
- Slide 5: Viz_5 (Radar Comparison) - 2 min
- Slide 6: Figure 6 (Clinical Workflow) - 3 min

**Poster Presentation:**
- Center: Figure 1 (large, eye-catching)
- Left: Figure 4 + Figure 5 (Methods)
- Right: Figure 2 + Figure 3 (Results)
- Bottom: Viz_5 (Comparison) + Viz_6 (Statistics)

### **For Thesis Defense:**

**Full Chapter Organization:**
- Chapter 3 (Methods): Figure 4, Figure 5, Viz_1
- Chapter 4 (Results): Figure 1, Figure 2, Figure 3, Viz_2, Viz_3
- Chapter 5 (Discussion): Viz_4, Viz_5, Viz_6, Figure 6

---

## üìà **TECHNICAL SPECIFICATIONS**

### **Resolution & Quality:**
- DPI: 300 (publication-grade)
- Format: PNG (lossless compression)
- Color Space: RGB
- Font: Times New Roman (academic standard)
- Grid: Anti-aliased for clarity

### **File Sizes:**
- Original: ~690 KB (comprehensive)
- Figures: 225-422 KB (optimized for manuscript)
- Advanced: 295-843 KB (detailed analytics)

### **Dimensions:**
- 2-panel: 14√ó5 inches (landscape)
- 4-panel: 14-16√ó10-12 inches (square)
- Single: 12√ó8 inches (portrait/landscape)

---

## ‚úÖ **QUALITY CHECKLIST**

**Visual Design:**
- ‚úÖ Professional color palette (colorblind-friendly)
- ‚úÖ Clear labels and annotations
- ‚úÖ Consistent font sizes (9-12pt)
- ‚úÖ Grid lines for readability
- ‚úÖ Legend placement optimized

**Content Completeness:**
- ‚úÖ All axes labeled with units
- ‚úÖ Titles descriptive and informative
- ‚úÖ Panel labels (A, B, C, D) for reference
- ‚úÖ Statistical annotations included
- ‚úÖ Reference lines where appropriate

**Data Integrity:**
- ‚úÖ All values match paper results
- ‚úÖ Calculations verified (precision, recall, F1)
- ‚úÖ Confusion matrix sums correct
- ‚úÖ Percentages accurate to 2 decimal places

**Publication Standards:**
- ‚úÖ 300 DPI minimum met
- ‚úÖ Font readable at printed size
- ‚úÖ Color contrast sufficient for B&W printing
- ‚úÖ Figure numbers match manuscript

---

## üìù **CITATION TEMPLATES**

### **In-Text Citations:**

```latex
% Training results
As shown in Figure 1A, validation accuracy improved from 57.76\% at episode 50 
to 91.57\% at episode 1000, representing a 33.81\% increase...

% Confusion matrix
The confusion matrix (Figure 2) demonstrates strong diagonal dominance with 
per-class recall ranging from 73.6\% (Meningioma) to 85.5\% (Glioma)...

% Per-class analysis
Per-class performance metrics (Figure 3) reveal balanced F1-scores across all 
tumor types, with Glioma achieving the highest score of 83.09\%...

% Architecture
The proposed architecture (Figure 4) employs a 4-layer convolutional network 
with 1.7M parameters to extract 128-dimensional embeddings...

% Episode structure
Each training episode (Figure 5) consists of 20 support samples (K=5 per class) 
and 40 query samples (N=10 per class), enabling meta-learning...

% Clinical workflow
The clinical deployment workflow (Figure 6) illustrates rapid adaptation to 
new hospitals using only 5 labeled samples per tumor class...
```

### **Figure Captions (LaTeX):**

```latex
\begin{figure}[htbp]
\centering
\includegraphics[width=\textwidth]{Figure_1_Training_Curves.png}
\caption{Training and validation performance over 1,000 episodes. 
(A) Accuracy progression showing improvement from 57.76\% to 91.57\% with 
learning rate milestones annotated. (B) Loss reduction demonstrating convergence 
with training loss decreasing from 0.98 to 0.41 and validation loss from 1.15 
to 0.40.}
\label{fig:training_curves}
\end{figure}

\begin{figure}[htbp]
\centering
\includegraphics[width=0.9\textwidth]{Figure_2_Confusion_Matrix.png}
\caption{Confusion matrix analysis on test set (1,000 images per class). 
(A) Absolute counts showing strong diagonal with correct predictions ranging 
from 736 to 855 per class. (B) Row-normalized percentages revealing recall rates: 
Glioma 85.5\%, Meningioma 73.6\%, No Tumor 81.8\%, Pituitary 80.6\%.}
\label{fig:confusion_matrix}
\end{figure}
```

---

## üîÑ **UPDATE HISTORY**

**Version 1.0** - December 4, 2025
- Initial generation of all 13 visualizations
- Publication figures (6): Complete manuscript figures
- Advanced analytics (6): Supplementary materials
- Original result: Comprehensive 6-panel overview

**Quality Assurance:**
- All values cross-checked with CSV results
- 300 DPI verified for all files
- Font consistency confirmed (Times New Roman)
- Color schemes tested for colorblind accessibility
- File sizes optimized (<1 MB each)

---

## üìö **RELATED DOCUMENTATION**

- **Main Paper:** PAPER_4_HASIL_PEMBAHASAN.md (results & discussion)
- **Methods:** PAPER_3_METODOLOGI.md (methodology details)
- **Code:** few_shot_meta_learning.py (implementation)
- **Data:** few_shot_meta_learning_results.csv (raw metrics)
- **Scripts:**
  - `generate_publication_figures.py` (Figure 1-6)
  - `generate_comprehensive_visualizations.py` (Viz 1-6)

---

## üéì **ACKNOWLEDGMENTS**

All visualizations created using:
- **Python 3.12+** with Matplotlib, Seaborn, NumPy
- **Design Principles:** Edward Tufte (data-ink ratio), ColorBrewer (palettes)
- **Standards:** IEEE, Nature, Science journal guidelines
- **Accessibility:** WCAG 2.1 AA color contrast compliance

---

## üìß **CONTACT FOR FIGURE MODIFICATIONS**

For custom figure requests, recoloring, or format conversions (PDF, EPS, SVG):
- Regenerate with modified scripts (Python code available)
- Adjust DPI in script (currently 300, can go to 600 for print)
- Change color schemes in COLORS dictionary
- Modify figure sizes in figsize parameters

---

**Document End** | Total Visualizations: 13 | Total Size: 5.43 MB | Quality: Publication-Ready ‚úÖ
